Results 211 to 220 of about 68,884 (253)
Some of the next articles are maybe not open access.
Pediatrics, 1996
The development and licensing of a vaccine for varicella in the United States has taken an incredible length of time. From the first report by Takahashi et al in 1974 until final American licensure in 1995, extensive studies were conducted by many investigators.
openaire +2 more sources
The development and licensing of a vaccine for varicella in the United States has taken an incredible length of time. From the first report by Takahashi et al in 1974 until final American licensure in 1995, extensive studies were conducted by many investigators.
openaire +2 more sources
Pediatric Clinics of North America, 2000
Varicella vaccine is safe, effective, and cost-effective in healthy children, adolescents, and adults. Breakthrough cases of MVLS are significantly milder than wild-type varicella infection. No severe adverse events have been reported following vaccination, and the incidence of herpes zoster is less in vaccinees than in individuals who have had natural
openaire +2 more sources
Varicella vaccine is safe, effective, and cost-effective in healthy children, adolescents, and adults. Breakthrough cases of MVLS are significantly milder than wild-type varicella infection. No severe adverse events have been reported following vaccination, and the incidence of herpes zoster is less in vaccinees than in individuals who have had natural
openaire +2 more sources
Archives of Pediatrics & Adolescent Medicine, 1981
J Z, Sullivan-Bolyai, A L, Smith
openaire +2 more sources
J Z, Sullivan-Bolyai, A L, Smith
openaire +2 more sources
Varicella and varicella vaccination. An update.
Australian family physician, 2004Although varicella is generally mild in children, it is often more severe in adults and overall is responsible for approximately 2000 hospital admissions each year in Australia. Live attenuated varicella vaccines have been available in Australia since 2000.
John, Litt, Margaret, Burgess
openaire +1 more source